Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 16, 2023

SELL
$0.89 - $2.52 $10,324 - $29,232
-11,600 Reduced 42.8%
15,500 $13,000
Q4 2022

Feb 14, 2023

SELL
$1.02 - $7.48 $64,770 - $474,980
-63,500 Reduced 70.09%
27,100 $31,000
Q3 2022

Nov 14, 2022

BUY
$6.04 - $9.66 $269,384 - $430,836
44,600 Added 96.96%
90,600 $682,000
Q2 2022

Aug 15, 2022

SELL
$4.99 - $8.96 $409,180 - $734,720
-82,000 Reduced 64.06%
46,000 $290,000
Q1 2022

May 16, 2022

BUY
$3.84 - $9.74 $274,944 - $697,384
71,600 Added 126.95%
128,000 $1.06 Million
Q4 2021

Feb 14, 2022

SELL
$5.12 - $8.19 $117,248 - $187,551
-22,900 Reduced 28.88%
56,400 $293,000
Q3 2021

Nov 15, 2021

SELL
$6.68 - $9.1 $1.09 Million - $1.48 Million
-162,800 Reduced 67.24%
79,300 $530,000
Q2 2021

Aug 11, 2021

BUY
$7.82 - $9.23 $3,128 - $3,692
400 Added 0.17%
242,100 $2.06 Million
Q1 2021

May 17, 2021

SELL
$8.44 - $12.66 $39,668 - $59,502
-4,700 Reduced 1.91%
241,700 $2.14 Million
Q4 2020

Feb 16, 2021

BUY
$7.98 - $12.29 $1.35 Million - $2.08 Million
169,000 Added 218.35%
246,400 $3.03 Million
Q3 2020

Nov 16, 2020

BUY
$7.96 - $12.42 $464,864 - $725,328
58,400 Added 307.37%
77,400 $630,000
Q4 2019

Feb 14, 2020

BUY
$9.77 - $15.66 $185,630 - $297,540
19,000 New
19,000 $283,000

Others Institutions Holding EIGR

About Eiger BioPharmaceuticals, Inc.


  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $418M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.